Nurix Therapeutics, Inc. NRIX Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s deferred tax assets and other non-current assets?
- Nurix Therapeutics, Inc. (NRIX) reported deferred tax assets and other non-current assets of $7.41M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Nurix Therapeutics, Inc.'s deferred tax assets and other non-current assets increased by 31.7% year-over-year, from $5.63M to $7.41M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s deferred tax assets and other non-current assets has grown at a 110.6% compound annual growth rate (CAGR), from $177K to $7.34M.